- Home
- TDUP vs HQL Comparison
TDUP vs HQL Comparison
Compare TDUP & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TDUP | HQL |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 745.9M | 689.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TDUP | HQL |
|---|---|---|
| Price | $2.16 | $17.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.24 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 118.8K |
| Earning Date | 11-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | ★ 75.36 | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $310,813,000.00 | N/A |
| Revenue This Year | $11.57 | N/A |
| Revenue Next Year | $10.33 | N/A |
| P/E Ratio | ★ N/A | $23.00 |
| Revenue Growth | ★ 19.53 | N/A |
| 52 Week Low | $2.09 | $15.60 |
| 52 Week High | $10.00 | $22.67 |
Technical Indicators
Market Signals| Indicator | TDUP | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 25.56 | 25.62 |
| Support Level | N/A | $16.15 |
| Resistance Level | $2.79 | $18.46 |
| Average True Range (ATR) | 0.11 | 0.53 |
| MACD | 0.04 | -0.17 |
| Stochastic Oscillator | 9.84 | 14.33 |
Price Performance
Historical ComparisonAbout TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for apparel, shoes, and accessories. The company's marketplaces have enabled buyers in the United States ("U.S.") to browse and purchase resale items principally for apparel, shoes, and accessories across a range of price points. The company's revenue is principally from the sale of secondhand apparel, shoes, and accessories on behalf of sellers.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.